Netrin-1 in cancer: Potential biomarker and therapeutic target?

Tumour Biol. 2017 Apr;39(4):1010428317698388. doi: 10.1177/1010428317698388.

Abstract

Netrin-1, a laminin-related protein, is known to be involved in the nervous system development. Recently, Netrin-1's involvement in other processes such as cell adhesion, motility, proliferation, and differentiation that are important for the development of epithelial tissues has been described. In addition, Netrin-1 and its receptors, deleted in colorectal cancer and uncoordinated-5 homolog, have been linked to apoptosis and angiogenesis. Since these properties are essential for tumor development, Netrin-1 and its receptors have been reported to promote tumorigenesis in many types of cancers. Here, we review the Netrin-1 mediated regulation of cancer, its potential use as a biomarker, and the targeting of the Netrin-1 pathway to treat cancers.

Keywords: Netrin-1; biomarker; cancer; dependence receptors; target; therapeutic.

Publication types

  • Review

MeSH terms

  • Biomarkers, Tumor / genetics*
  • Humans
  • Molecular Targeted Therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Nerve Growth Factors / genetics*
  • Nerve Growth Factors / therapeutic use
  • Netrin-1
  • Tumor Suppressor Proteins / genetics*
  • Tumor Suppressor Proteins / therapeutic use

Substances

  • Biomarkers, Tumor
  • NTN1 protein, human
  • Nerve Growth Factors
  • Tumor Suppressor Proteins
  • Netrin-1